|
|
|
Insider
Information: |
Kapusta Matthew C |
Relationship: |
Director |
City: |
Germantown |
State: |
TN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
620,901 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,141,678 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
620,901 |
|
|
Total
Value |
$3,141,678 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
10
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
8
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-299.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Angiodynamics Inc |
ANGO |
SVP, Business Developm... |
2014-11-17 |
30,062 |
2012-04-10 |
0 |
Premium* |
|
uniQure B.V. |
QURE |
CEO, Managing Director... |
2024-03-01 |
590,839 |
2017-12-13 |
0 |
Premium* |
|
Decibel Therapeutics, Inc. |
DBTX |
Director |
2023-09-25 |
0 |
2023-03-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
79 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2020-08-25 |
4 |
AS |
$40.27 |
$12,081 |
D/D |
(300) |
293,314 |
0 |
% |
|
ANGO |
Angiodynamics Inc |
SVP, Business Development |
|
2013-08-03 |
4 |
D |
$12.04 |
$6,381 |
D/D |
(530) |
19,112 |
0 |
- |
|
ANGO |
Angiodynamics Inc |
SVP, Business Development |
|
2014-08-03 |
4 |
D |
$14.69 |
$7,786 |
D/D |
(530) |
31,280 |
0 |
- |
|
ANGO |
Angiodynamics Inc |
SVP, Business Development |
|
2014-08-06 |
4 |
D |
$14.75 |
$8,496 |
D/D |
(576) |
30,704 |
0 |
- |
|
ANGO |
Angiodynamics Inc |
SVP, Business Development |
|
2012-04-10 |
4 |
B |
$11.40 |
$11,397 |
D/D |
1,000 |
16,000 |
2.74 |
- |
|
ANGO |
Angiodynamics Inc |
SVP, Business Development |
|
2014-04-14 |
4 |
B |
$13.90 |
$13,900 |
D/D |
1,000 |
27,005 |
2.74 |
- |
|
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2021-07-14 |
4 |
AS |
$27.77 |
$27,770 |
D/D |
(1,000) |
257,577 |
0 |
% |
|
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2021-08-18 |
4 |
AS |
$28.08 |
$28,146 |
D/D |
(1,000) |
256,577 |
0 |
% |
|
ANGO |
Angiodynamics Inc |
SVP, Business Development |
|
2012-11-15 |
4 |
D |
$10.12 |
$13,743 |
D/D |
(1,358) |
19,642 |
0 |
- |
|
ANGO |
Angiodynamics Inc |
SVP, Business Development |
|
2013-11-15 |
4 |
D |
$15.62 |
$21,743 |
D/D |
(1,392) |
23,158 |
0 |
- |
|
ANGO |
Angiodynamics Inc |
SVP, Business Development |
|
2014-11-17 |
4 |
D |
$16.85 |
$23,455 |
D/D |
(1,392) |
30,062 |
0 |
- |
|
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2021-06-17 |
4 |
AS |
$35.00 |
$66,500 |
D/D |
(1,900) |
258,577 |
0 |
% |
|
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2021-03-17 |
4 |
AS |
$32.95 |
$74,617 |
D/D |
(2,250) |
271,527 |
0 |
% |
|
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2021-05-12 |
4 |
AS |
$32.29 |
$72,653 |
D/D |
(2,250) |
263,927 |
0 |
% |
|
QURE |
uniQure B.V. |
CEO, Managing Director |
|
2023-03-07 |
4 |
S |
$21.39 |
$53,924 |
D/D |
(2,521) |
468,743 |
0 |
% |
|
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2020-11-19 |
4 |
OE |
$7.53 |
$23,531 |
D/D |
3,125 |
276,592 |
0 |
- |
|
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2020-11-18 |
4 |
OE |
$7.53 |
$24,216 |
D/D |
3,216 |
283,780 |
0 |
- |
|
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2021-06-16 |
4 |
AS |
$34.26 |
$119,453 |
D/D |
(3,450) |
260,477 |
0 |
% |
|
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2021-02-15 |
4 |
AS |
$34.88 |
$134,452 |
D/D |
(3,800) |
222,938 |
0 |
% |
|
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2020-01-31 |
4 |
AS |
$57.98 |
$224,499 |
D/D |
(3,872) |
264,541 |
0 |
% |
|
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2020-08-19 |
4 |
AS |
$38.72 |
$168,175 |
D/D |
(4,300) |
293,614 |
0 |
% |
|
ANGO |
Angiodynamics Inc |
SVP, Business Development |
|
2014-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,805 |
31,810 |
0 |
- |
|
QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
|
2021-03-02 |
4 |
S |
$36.94 |
$183,740 |
D/D |
(4,974) |
273,777 |
0 |
% |
|
ANGO |
Angiodynamics Inc |
SVP, Business Development |
|
2012-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
21,000 |
0 |
- |
|
QURE |
uniQure B.V. |
CEO, Managing Director |
|
2023-02-28 |
4 |
S |
$20.90 |
$104,939 |
D/D |
(5,021) |
471,264 |
0 |
% |
|
79 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|